Stay updated on Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page's related topics section now includes Melanoma and a MedlinePlus Genetics link, expanding topic associations for readers. The revision version has been updated from v3.6.2 to v3.6.3.
    Difference
    0.2%
    Check dated 2026-07-05T14:43:36.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.6.0 to v3.6.2, signaling a newer version of the page. The update is a metadata revision with no impact on the displayed study details.
    Difference
    0.1%
    Check dated 2026-06-28T09:06:45.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page's related topics/MeSH metadata no longer lists Melanoma and MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2026-06-20T22:15:34.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page adds recruitment status text ('No longer looking for participants'), introduces new help and navigation sections, and updates the revision label, while a heading formatting change standardizes 'Intervention/Treatment'.
    Difference
    0.6%
    Check dated 2026-06-13T17:47:33.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.5 and some related topics and an older revision tag were removed, indicating a minor metadata cleanup.
    Difference
    0.2%
    Check dated 2026-06-06T14:19:04.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    The page now includes additional related topics and links: Melanoma and MedlinePlus Genetics. These additions provide extra context without altering the study details.
    Difference
    0.2%
    Check dated 2026-05-30T12:34:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.